Additionally, GTS-21 could be another candidate for targeting α7 nAChR, as it showed promising effects on peripheral blood mononuclear cells isolated from samples of COPD patients and healthy controls [46]. This evidence concerns the gene CHRNA7 and chronic obstructive pulmonary disease.